Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.680
+0.110 (7.01%)
At close: Jun 26, 2026, 4:00 PM EDT
1.660
-0.020 (-1.19%)
After-hours: Jun 26, 2026, 7:06 PM EDT
Caribou Biosciences Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Caribou Biosciences stock have an average target of 9.00, with a low estimate of 4.00 and a high estimate of 13. The average target predicts an increase of 435.71% from the current stock price of 1.68.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Caribou Biosciences stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 7 | 7 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $11 | Buy | Reiterates | $11 | +554.76% | Jun 16, 2026 |
| Citi | Citi | Buy Maintains $8 | Buy | Maintains | $8 | +376.19% | Jun 12, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $6 | Buy | Maintains | $6 | +257.14% | Jun 12, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $10 | Buy | Maintains | $10 | +495.24% | May 8, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $11 → $13 | Buy | Maintains | $11 → $13 | +673.81% | Mar 9, 2026 |
Financial Forecast
Revenue This Year
25.66M
from 11.16M
Increased by 129.99%
Revenue Next Year
30.08M
from 25.66M
Increased by 17.20%
EPS This Year
-1.25
EPS Next Year
-1.40
from -1.25
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 100.0M | 100.0M | |
| Avg | 25.7M | 30.1M | |
| Low | 9.9M | 11.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 796.1% | 289.6% | |
| Avg | 130.0% | 17.2% | |
| Low | -11.3% | -55.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.15 | -1.32 | |
| Avg | -1.25 | -1.40 | |
| Low | -1.36 | -1.48 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.